NanoViricides Inc. (NNVC)

[JG36]

I'm pretty sure the NYSE did not get into the details of the science and try to figure out if nanoviricides really work and are safe to take. That's outside of their area of expertise. They look at the share price, and how much money NNVC has in the bank, make sure the financial reporting meets the standards, and so forth. Whether the company is likely to succeed or not is up to the investors to decide, its not the job of the NYSE to determine that. If the NYSE only listed biotech start ups they could be very confident would succeed they would only list those companies that had at least gotten through phase II trials.